Cargando…

Expanding the Repertoire of Biomarkers for Alzheimer’s Disease: Targeted and Non-targeted Approaches

The first biofluid markers developed for Alzheimer’s disease (AD) used targeted approaches for discovery. These initial biomarkers were directed at key protein constituents of the hallmark brain lesions in AD. Biomarkers for plaques targeted the amyloid beta protein (Aβ) and for tangles, the microtu...

Descripción completa

Detalles Bibliográficos
Autor principal:	Galasko, Douglas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680926/ https://www.ncbi.nlm.nih.gov/pubmed/26733934 http://dx.doi.org/10.3389/fneur.2015.00256

Ejemplares similares

Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Their Role in Clinical Chemistry
por: Blennow, Kaj, et al.
Publicado: (2000)

Dicer partners expand the repertoire of miRNA targets
por: Jaskiewicz, Lukasz, et al.
Publicado: (2012)

The Role of Non-coding RNAs in Alzheimer’s Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers
por: Zhang, Yuan, et al.
Publicado: (2021)

Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems
por: Galasko, Douglas, et al.
Publicado: (2013)

Targeting the Synapse in Alzheimer’s Disease
por: Jackson, Johanna, et al.
Publicado: (2019)

Editorial: Experimental and Innovative Approaches to Multi-Target Treatment of Parkinson's and Alzheimer's Diseases
por: Tikhonova, Maria A., et al.
Publicado: (2022)

Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
por: Zhao, Jing, et al.
Publicado: (2020)

Expanded target and cofactor repertoire for the transcriptional activator LysM from Sulfolobus
por: Song, Ningning, et al.
Publicado: (2013)

Expanding the Repertoire of Target Sites for Zinc Finger Nuclease-mediated Genome Modification
por: Wilson, Kimberly A, et al.
Publicado: (2013)

Expanding the repertoire of glucocorticoid receptor target genes by engineering genomic response elements
por: Thormann, Verena, et al.
Publicado: (2019)

Biomarkers in Alzheimer’s Disease
por: Riverol, Mario, et al.
Publicado: (2011)

Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer's disease-experimental approach and therapeutic implications
por: Wang, Jun, et al.
Publicado: (2014)

Editorial: Experimental and innovative approaches to multi-target treatment of Parkinson's and Alzheimer's diseases - Volume II
por: Tikhonova, Maria A., et al.
Publicado: (2023)

Targeting Autophagy for the Treatment of Alzheimer’s Disease: Challenges and Opportunities
por: Liu, Jie, et al.
Publicado: (2019)

Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
por: Huang, Yuehua, et al.
Publicado: (2022)

An atlas on biomarkers for Alzheimer's disease
por: Martínez-Rivera, Marta
Publicado: (2013)

Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD
por: Hedl, Thomas J., et al.
Publicado: (2019)

Expanding the Regulatory Repertoire of GEFs
por: Robinson, Richard
Publicado: (2013)

An Expanding Repertoire of Protein Acylations
por: Xu, Yuxuan, et al.
Publicado: (2022)

The Fourth Element Targeting Hypothesis of Alzheimer's Disease Pathogenesis and Pathophysiology
por: Kuljiš, Rodrigo O.
Publicado: (2010)

Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities
por: Hemonnot, Anne-Laure, et al.
Publicado: (2019)

Editorial: Identification of Multiple Targets in the Fight Against Alzheimer's Disease
por: Giannoni, Patrizia, et al.
Publicado: (2020)

Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease
por: Dwomoh, Louis, et al.
Publicado: (2022)

Multi-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease
por: Gong, Cheng-Xin, et al.
Publicado: (2022)

Recent Alzheimer's disease research highlights
por: Galasko, Douglas, et al.
Publicado: (2012)

Targeted Discovery and Validation of Plasma Biomarkers of Parkinson’s Disease
por: Pan, Catherine, et al.
Publicado: (2014)

Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer’s Disease
por: Yin, Qingqing, et al.
Publicado: (2020)

Targeting Adenosine Signaling in Parkinson's Disease: From Pharmacological to Non-pharmacological Approaches
por: Nazario, Luiza R., et al.
Publicado: (2017)

The Eye As a Biomarker for Alzheimer's Disease
por: Lim, Jeremiah K. H., et al.
Publicado: (2016)

Electrophysiological Biomarkers of Epileptogenicity in Alzheimer’s Disease
por: Yu, Tingting, et al.
Publicado: (2021)

Central Nervous System and Peripheral Inflammatory Processes in Alzheimer’s Disease: Biomarker Profiling Approach
por: Delaby, Constance, et al.
Publicado: (2015)

NPTX2 and cognitive dysfunction in Alzheimer’s Disease
por: Xiao, Mei-Fang, et al.
Publicado: (2017)

Right sizing funding for Alzheimer's disease
por: Golde, Todd E, et al.
Publicado: (2011)

Effects of Alzheimer’s Disease on Visual Target Detection: A “Peripheral Bias”
por: Vallejo, Vanessa, et al.
Publicado: (2016)

Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease
por: Snow, Wanda M., et al.
Publicado: (2016)

The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
por: Cellai, Lucrezia, et al.
Publicado: (2018)

Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer’s Disease
por: Ortí-Casañ, Natalia, et al.
Publicado: (2019)

TMP21 in Alzheimer’s Disease: Molecular Mechanisms and a Potential Target
por: Qiu, Kaixin, et al.
Publicado: (2019)

Slow Wave Sleep Is a Promising Intervention Target for Alzheimer’s Disease
por: Lee, Yee Fun, et al.
Publicado: (2020)

Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
por: Reich, Niklas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dabv752r3t6695b9pkr94fjdfq